Allara Health, a virtual women’s health provider, has expanded to all 50 states.
The provider, specializing in women’s hormonal, metabolic and reproductive health, was in 30 states at the start of the year. Alongside news of the expansion, Allara has also published clinical outcomes data that demonstrate improvements in patient health in a health impact report.
The retrospective analysis included nearly 1,500 patients who either had a PCOS diagnosis or were being seen for other hormonal or metabolic care. It found that in the first nine months of care, patients with a body mass index (BMI) in the obese range (equal to or greater than 30) achieved a 5% mean BMI reduction. A 5% weight reduction is considered clinically significant, the report said.
The analysis also found that after 10 months, two-thirds of prediabetic patients had normalized their A1C levels, and 77% of diabetics reduced their A1C levels out of the diabetic range. Patients with a high level of insulin resistance saw a 12% reduction in those levels.
Millions of women are affected by hormonal conditions like PCOS, endometriosis or thyroid disorders, which can raise the risk of other chronic conditions. These conditions can also impact fertility. Yet these conditions remain underdiagnosed and undertreated. Seven in 10 Allara patients have a chronic hormonal condition, and 60% or more are obese and/or have insulin resistance.
Rachel Blank founded Allara after her own frustrating experience getting diagnosed with PCOS and searching for answers. Coordinating between specialists, Blank felt like she was “bouncing around the system” and had to fight to be taken seriously, she recalled.
“It felt like this very lack of a preventative approach,” Blank told Fierce Healthcare.
She saw a need in the market for a provider that can take care of a woman’s complex needs through every life stage. Allara’s philosophy is to proactively address symptoms and their underlying causes as they arise and before they spin out into other conditions. Two-thirds of Allara patients come to the company without a diagnosis.
Each Allara patient is paired with a multidisciplinary team, including OB-GYNs, endocrinologists, registered dietitians and patient success leads. This approach shortens time to diagnosis to a matter of weeks, per Blank. Initial visits with medical providers are at least 30 minutes long and can be up to an hour long with registered dietitians. So far, the company is seeing results.
In a 2025 patient experience survey that reached nearly 400 participants, 7 in 10 Allara patients who previously had irregular periods reported improved menstrual regularity. Nearly all patients said they felt supported in making positive health changes. Three-quarters reported improvements to diet, and more than half reported improvements to exercise habits. Most (84%) also reported improved productivity at work, and 96% found the program helpful in fertility planning.
Allara patients meet with their care team regularly via video on average up to six times in their first year. “To be able to see a provider virtually … allows us to minimize disruptions to a patient’s life,” Blank said. This is reflected in the survey findings around improved productivity. “Having that very integrated, lifelong care partner is not so easy to find.”
While all of Allara’s care is offered virtually, Allara has a referral network for when patients need in-person services, including mental health support, labs, ultrasounds, obstetric care, IVF or social needs.
The company, which began seeing patients four years ago, has served more than 40,000 women to date and says it saves more than $3,000 per patient annually. These savings come from avoiding diabetes-related costs, obesity-related complications and fertility-related expenses.
Allara has raised more than $40 million, with a $26 million series B funding round announced earlier this year. Allara works with most major payers across the country, and 95% of Allara patients use insurance today. It is exploring Medicaid partnerships.
“A lot of the reason that I started this business was to get better access to healthcare for as many women as possible, and insurance has been a big driver of that,” Blank said.
While Allara was initially founded to treat PCOS, it has since expanded into chronic condition management, metabolic health dysfunction, weight management and perimenopause. Next year, Allara hopes to introduce fertility and pregnancy support as well. Allara is able to prescribe medications, including hormone therapy and GLP-1s, but not controlled substances.
Blank is excited about Allara being able to lean into its data to help research women’s health, historically an underfunded area.
“As we build out this very large patient data set in women’s health, we’re able to not only contribute to the general research around women's health, but really use the data that we’re getting to drive better clinical outcomes and a better clinical model,” Blank said.